Log in or Sign up for Free to view tailored content for your specialty!
Drug/Insect/Latex News
VIDEO: Strategies can help maintain drug allergy de-label
ANAHEIM, Calif. — Utilizing technology and patient education are strategies that can maintain a drug allergy de-label, Allison C. Ramsey, MD, FACAAI, said at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
C1 inhibitor prevents adverse events from immunoglobulin replacement therapy
ANAHEIM, Calif. — A woman who could not tolerate immunoglobulin replacement therapy benefitted from C1-INH replacement therapy, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Allergists can guide patients through medical waivers in military enlistment
ANAHEIM, Calif. — Allergists can help adolescents and young adults with atopic conditions enlist in the military, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
ChatGPT accurately, yet sometimes inconsistently, debunks many allergy myths
ANAHEIM, Calif. — ChatGPT answered accurately or somewhat accurately 91% of the time when asked about 10 allergy myths, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Options exist to manage immune-mediated adverse reactions to insulin
ANAHEIM, Calif. — Patients with insulin allergy were treated successfully with omalizumab, rituximab and/or mycophenolate, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Protocol eliminates or mitigates hypersensitivity reactions to iodinated contrast media
A two-track protocol helped physicians select safe iodinated contrast media for patients with immediate hypersensitivity reactions, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Q&A: Patients with verified penicillin allergies safely receive cephalosporins
High-risk patients who had a verified penicillin allergy safely received cephalosporins, according to a letter published in The Journal of Allergy and Clinical Immunology: In Practice.
Symptom patterns emerge in NSAID-exacerbated respiratory disease development
Age, sex, ethnicity, BMI and environmental exposures were associated with different patterns in NSAID-exacerbated respiratory disease development, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.
Testing clears nearly all antibiotic allergy labels in pediatric clinic
A pediatric allergy clinic safely delabeled nearly all the patients with reported antibiotic allergy that it tested between January 2016 and December 2017, according to a letter published in Annals of Allergy, Asthma & Immunology.
Top news of August: Patient-provider relationships, mold and mildew, schizophrenia, more
Healio compiled the most-read news in allergy, asthma and immunology posted in August.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read